The essential oils of seven aromatic plants from central west Argentina were isolated by steam distillation and analyzed by a gas chromatography/mass spectrometry technique. The oils were screened for cytotoxicity and in vitro inhibitory activity against herpes simplex virus type 1 (HSV-1), dengue virus type 2 (DENV-2) and Junin virus (JUNV). The oils showed a variable virucidal action according to the virus. JUNV was the least susceptible virus in comparison with HSV-1 and DENV-2. The better relationship between cytotoxicity and inhibitory activity was observed for the essential oil of Lantana grisebachiii (Seckt.) var. grisebachii against DENV-2 and HSV-1 with IC 50 (inhibitory concentration 50%) values of 21.1 and 26.1 ppm, respectively. This effect was specific since the selectivity indices (ratio cytotoxicity/virucidal activity) were > 23.7 and > 19.1 for DENV-2 and HSV-1, respectively. Furthermore, the oil from L. grisebachii was also an effective inhibitor of HSV-2 and acyclovir resistant variants of herpes virus. This study demonstrates the effective and selective inhibitory activity of the essential oil from Lantana grisebachii against HSV and DENV by direct virus inactivation.
Traditional medicine is still a main tool for health care in many developing countries. Due to their chemical diversity, natural products have a substantial impact on the drug discovery process in all major therapeutic areas [1, 2] . Particularly, essential oils obtained from many plants have been widely used in phytotherapy and diverse biological activities, including antimicrobial, immunomodulatory, antioxidant and antiinflamatory properties, were described for these natural substances [3] [4] [5] . In recent years, the antiviral activity of essential oils from different plant sources has been reported [6] [7] [8] [9] [10] [11] [12] [13] .
The central west region of Argentina, including the provinces of Córdoba and San Luis, is one of the main suppliers of native aromatic and medicinal species to the national market. In this paper, the essential oils extracted from seven aromatic plants of this zone were evaluated for their virus-inhibitory activity against herpes simplex virus (HSV), dengue virus (DENV) and Junin virus (JUNV). The present study was aimed at finding new agents with prophylactic and/or therapeutic activity against these three human pathogens.
Gas chromatographic (GC) and GC-mass spectrometric (GC-MS) analyses allowed us to identify 50-60 compounds that represent approximately 90% of the essential oil of the seven species of plants here studied. The major components are listed in Table 1 . As seen, several differences in chemical composition from a qualitative and quantitative point of view could be detected when comparing all the analyzed oil samples.
The degree of toxicity for Vero cells of the essential oils was then investigated by assessing their effects on cell viability by MTT assay. The 50% cytotoxic concentration values (CC 50 ) were variable in a wide range from 40 to >500 ppm (Table 2) . Therefore, the inhibitory activity against HSV-1, JUNV, and DENV-2 of the essential oils was examined at concentrations below the CC 50 by a virucidal assay, to obtain the 50% inhibitory concentration (IC 50 ). Among the tested plants, L. floribunda, C. aculeata and L. camara were not considered active against the three viruses because the ratio between cytotoxicity and virucidal activity (selectivity index: CC 50 / IC 50 ) was in the range 1-3.8 in all cases, indicating the lack of a significant specificity in the inhibitory effect against the virus. For the other four evaluated plants, the activity of the essential oils was variable according to the virus. In general, JUNV was the least susceptible virus with IC 50 values greater than 250 ppm, with the only exception being the oil from T. divaricata, which showed the lowest IC 50 value of 18.6 ppm against JUNV. As seen in Table 2 , the oils from L. grisebachii, E. catarium and E. arnottianum presented better relationships between cytotoxicity and anti-DENV-2 and anti-HSV-1 activity.
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In particular, the most potent inhibition was observed with the essential oil of L. grisebachii against DENV-2 To assess further the potential of the oil of L. grisebachii as an anti-herpes agent, its efficacy against the other serotype, HSV-2 strain G, and against an acyclovir (ACV)-resistant, thymidine kinase negative (TK -), strain (Field) of HSV-1 was evaluated. The oil was an effective inhibitor of both strains with IC 50 values of 44.3 and 79.7 ppm for HSV-2 and HSV-1 Field, respectively.
In conclusion, these studies have shown the selective virucidal activity of essential oils from L. grisebachii against two widely disseminated human pathogenic viruses. Essential oils are complex mixtures of compounds, with predominance of terpenes, terpenoids and their derivatives. The presence of this type of compound could in part explain their activity on cellfree viruses by interaction with the viral envelope. Previous reports with other plants have also shown that essential oils are active when the virus was preincubated with compounds before attachment to the host cells and no significant effect could be achieved by adding these compounds during the replication phase [6, 8, 10, 12] Here, the L. grisebachii oil was very effective in inactivating reference strains of HSV-1 and HSV-2, as well as an ACV-resistant TKstrain of HSV-1, confirming, in this last case, that the mechanism of action for both inhibitors is different. It remains to be determined if the inactivating effect of the essential oil might be due to interference with the envelope structure required for adsorption or entry into the cell or to disruption of the envelope by lipophilic compounds.
Given the effectiveness of the oil to kill virion infectivity before cell infection, the better perspective of application of this type of natural product is its preventive use as a disinfectant or topical medicament. Other plant products were tested for microbicidal action in vitro and in vivo [14] [15] [16] . The local application of Virucidal activity of essential oil Natural Product Communications Vol. 5 (8) 2010 1309 essential oils with a high selectivity index, like L. grisebachii oil, at mucosal surfaces appears to be a promising therapeutic alternative to be further investigated for prevention and treatment of recurrent herpes virus infections. 
Experimental

Isolation and analysis of essential oils:
The aerial parts of the samples were air-dried in the shade at room temperature. The oils were obtained by water distillation during 3 h using a Clevenger-type apparatus. The oils were dried over anhydrous sodium sulfate and kept at -18ºC in a dark bottle.
Analysis of the oils by GC was carried out using a Hewlett Packard 5890 series II instrument, with a FID detector, equipped with a HP5 column (5% phenylmethyl-siloxane, 30 m x 0.25 mm, thickness of film 0.25 µm) using N 2 as carrier gas (1.1 mL/min). The oven temperature program was: 60°C (1 min), 60 -185°C (1.5°C/min), 185ºC (1 min.), 185 -275ºC (9ºC/min), 275°C (1 min.). Injection volume 0.1 µL (split 1: 80), temperature of the injection port 250ºC and detector 270ºC. The percentage compositions were obtained from electronic integration measurements using FID. The analysis by GC-MS was carried out in GC-HP equipment with a selective detector of 6890 masses quadrupole HP5973, with a HP5-MS column (5% phenyl-methyl-siloxane, 30 m x 0.25 mm, thickness of film 0.25 µm), with helium (1 mL/min) as carrier gas , injection port 250ºC, source of MS 230ºC, quadrupole 150ºC, auxiliary 280ºC. The volume of injection and temperature program were the same as above. The identification of oil components was based on comparison of their mass spectra with those found in the literature [17] , a computer search of MS data bank (NIST) and Wiley library, and by Kovats indices calculated by co-injection with a homologous series of n-alkanes (C 8 -C 18 ).
Stock solutions were prepared by dissolving each essential oil in Tween 80-ethanol (1:0.5) and then diluted in maintenance medium to perform the biological tests.
Cells and viruses:
Vero (African green monkey kidney) cells were grown as monolayers in Eagle's minimum essential medium (MEM) supplemented with 5% inactivated calf serum. For maintenance medium (MM), the serum concentration was reduced to 1.5%. The C6/36 mosquito cell line from Aedes albopictus was cultured at 33°C in L-15 Medium (Leibovitz) supplemented with 0.3% tryptose phosphate broth, 0.02% glutamine, 1% MEM non-essential amino acids solution and 5% fetal calf serum.
The virus strains used were: JUNV strain IV4454, DENV-2 strain NGC, HSV-1 strain F, HSV-2 strain G and the ACV-resistant TK -HSV-1 strain Field. DENV-2 stocks were prepared in C6/36 cells and titrated by plaque formation in Vero cells. JUNV, HSV-1 and HSV-2 were prepared and titrated in Vero cells.
Cytotoxicity test: Vero cell viability was measured by the 4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) (Sigma-Aldrich, St. Louis, MO, USA) method. Confluent cultures in 96-well plates were exposed to different concentrations of the compounds, 3 wells for each concentration, and incubated for 48 h at 37°C. Then, 10 µL of MM containing MTT (final concentration 5 µg/mL) was added to each well. After 2 h of incubation at 37°C, the supernatant was removed, 200 µL of ethanol was added to each well to solubilize the formazan crystals, and absorbance was measured in a microplate reader at 595 nm. The CC 50 was calculated as the compound concentration required to reduce cell viability by 50%.
Virucidal assay:
A virus suspension containing approximately 10 6 PFU was incubated with an equal volume of MM with or without different concentrations of the compounds for 1.5 h at 37°C. A control virus sample in MM containing the solvent used to prepare the essential oil solution was also prepared. The samples were then diluted in MM to determine residual infectivity in a plaque formation assay using Vero cells. The ratios of virus titer in compound-treated samples with respect to virus titer in control samples were calculated, and then the IC 50 , defined as the concentration required to inactivate virions by 50%, was determined.
